Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Awakn, Cytodyn, Dynavax, Emmaus, F-star, Gilead, Hao Tian, Humanigen, Idorsia, Immuron, Kalytera, Kronos, Mallinckrodt, Marinomed, Merck & Co., Merck KGaA, Mydecine, Nabriva, Neuropharm, Novartis, Oncorus, Ose, Promethera, Recce, Scynexis, Silence, Summit, Tevogen, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC, Algernon, Aprea, Arcutis, Astrazeneca, Calcimedica, Fab'entech, Heron, Ideaya, Neurorx, Oncorus, Relief, Rhythm, Santen.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acacia, Anheart, Basilea, Bold, Bridge, BSP, Can-Fite, CNS, Cosmo, Dyadic, Eloxx, Evoke, Glaxosmithkline, Idbiologics, Immuneoncia, Moleculin, MSD, Newg, Nyrada, Octapharma, Orchard, Patheon, Pfizer, Pharmaceutics International, Samsung, Sterling, Tiziana, TLC, Twist, Valbiotis, Vivasc, Zyus.

Keeping you up to date on recent developments in orthopedics, including: Primitive stem cells point to new bone grafts for stubborn-to-heal fractures; Orthopedic surgeons issue guidelines on resuming elective surgery amid COVID-19 pandemic; Cardiac CT can double as osteoporosis test; Novel bone imaging approach provides insights into the progression of knee osteoarthritis.

The latest global regulatory news, changes and updates affecting biopharma, including: Ono Pharmaceuticals.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Bioaegis, Boehringer, GSK, Knopp, Lintonpharm, Neoimmunetech, Oramed.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamas, Bellerophon, Bridge, Byondis, Cure, Deinove, Essa, Evofem, Moderna, Nicox, QED, Ribomic, Valbiotis, Vivoryon.